Milestone Pharmaceuticals Reports Lower Loss But Misses Estimates

Milestone Pharmaceuticals reported a reduced loss compared to last year but fell short of analysts' expectations, indicating a challenging outlook. Their latest loss was $41.52 million or $0.67 per share.

Date: 13-03-2025

AI Rating: 5

Overview of Financial Performance

Milestone Pharmaceuticals Inc (MIST) reported a loss of $41.52 million, equating to an earnings per share (EPS) of -$0.67, an improvement over the previous year's loss of $59.69 million or -$1.39 EPS. While the company did show a reduction in losses, it fell short of analysts' expectations, which had projected an EPS of -$0.61.

This outcome highlights a mixed performance: while there is a noteworthy improvement in reducing losses year-over-year, the inability to meet analysts' expectations may raise concerns among investors.

Stocks: MIST